Literature DB >> 20864674

Unexpected vascular enrichment of SCO1 over SCO2 in mammalian tissues: implications for human mitochondrial disease.

Sonja Brosel1, Hua Yang, Kurenai Tanji, Eduardo Bonilla, Eric A Schon.   

Abstract

Mammalian SCO1 and SCO2 are evolutionarily-related copper-binding proteins that are required for the assembly of cytochrome c oxidase (COX), a mitochondrial respiratory chain complex, but the exact roles that they play in the assembly process are unclear. Mutations in both SCO1 and SCO2 are associated with distinct clinical phenotypes as well as tissue-specific COX deficiency, but the reason for such tissue specificity is unknown. We show in this study that although both genes are expressed ubiquitously in all mouse and human tissues examined, surprisingly, SCO1 localizes predominantly to blood vessels, whereas SCO2 is barely detectable in this tissue. To our knowledge, SCO1 is the first known example of a mitochondrial protein that is strongly expressed in the vasculature. We also show that the expression of SCO1, but not of SCO2, is very high in liver (the tissue most affected in SCO1-mutant patients), whereas the reverse holds true in muscle (the tissue most affected in SCO2-mutant patients). Our findings may help explain the differences in clinical presentations due to mutations in SCO1 and SCO2 and provide clues regarding the partially nonoverlapping functions of these two proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864674      PMCID: PMC2966810          DOI: 10.2353/ajpath.2010.100229

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA.

Authors:  K Nakada; K Inoue; T Ono; K Isobe; A Ogura; Y I Goto; I Nonaka; J I Hayashi
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

2.  Cytochrome c oxidase assembly factors with a thioredoxin fold are conserved among prokaryotes and eukaryotes.

Authors:  Y V Chinenov
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

3.  Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts.

Authors:  M Jaksch; C Paret; R Stucka; N Horn; J Müller-Höcker; R Horvath; N Trepesch; G Stecker; P Freisinger; C Thirion; J Müller; R Lunkwitz; G Rödel; E A Shoubridge; H Lochmüller
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

4.  Mammalian subunit IV isoforms of cytochrome c oxidase.

Authors:  M Hüttemann; B Kadenbach; L I Grossman
Journal:  Gene       Date:  2001-04-04       Impact factor: 3.688

5.  Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene.

Authors:  L C Papadopoulou; C M Sue; M M Davidson; K Tanji; I Nishino; J E Sadlock; S Krishna; W Walker; J Selby; D M Glerum; R V Coster; G Lyon; E Scalais; R Lebel; P Kaplan; S Shanske; D C De Vivo; E Bonilla; M Hirano; S DiMauro; E A Schon
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

6.  Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy.

Authors:  I Valnot; S Osmond; N Gigarel; B Mehaye; J Amiel; V Cormier-Daire; A Munnich; J P Bonnefont; P Rustin; A Rötig
Journal:  Am J Hum Genet       Date:  2000-09-28       Impact factor: 11.025

7.  Mitochondrial copper metabolism in yeast: interaction between Sco1p and Cox2p.

Authors:  A Lode; M Kuschel; C Paret; G Rödel
Journal:  FEBS Lett       Date:  2000-11-17       Impact factor: 4.124

8.  Analysis of mouse models of cytochrome c oxidase deficiency owing to mutations in Sco2.

Authors:  Hua Yang; Sonja Brosel; Rebeca Acin-Perez; Vesna Slavkovich; Ichizo Nishino; Raffay Khan; Ira J Goldberg; Joseph Graziano; Giovanni Manfredi; Eric A Schon
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

9.  Cytochrome c oxidase of mammals contains a testes-specific isoform of subunit VIb--the counterpart to testes-specific cytochrome c?

Authors:  Maik Hüttemann; Saied Jaradat; Lawrence I Grossman
Journal:  Mol Reprod Dev       Date:  2003-09       Impact factor: 2.609

10.  Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations.

Authors:  Leonardo Salviati; Evelyn Hernandez-Rosa; Winsome F Walker; Sabrina Sacconi; Salvatore DiMauro; Eric A Schon; Mercy M Davidson
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

View more
  4 in total

1.  No Evidence for Association of SCO2 Heterozygosity with High-Grade Myopia or Other Diseases with Possible Mitochondrial Dysfunction.

Authors:  Dorota Piekutowska-Abramczuk; Beata Kocyła-Karczmarewicz; Maja Małkowska; Sylwia Łuczak; Katarzyna Iwanicka-Pronicka; Stephanie Siegmund; Hua Yang; Quan Wen; Quan V Hoang; Ronald H Silverman; Paweł Kowalski; Olga Szczypińska; Kamila Czornak; Janusz Zimowski; Rafał Płoski; Jacek Pilch; Elżbieta Ciara; Jacek Zaremba; Małgorzata Krajewska-Walasek; Eric A Schon; Ewa Pronicka
Journal:  JIMD Rep       Date:  2015-10-02

2.  Cardiac deficiency of single cytochrome oxidase assembly factor scox induces p53-dependent apoptosis in a Drosophila cardiomyopathy model.

Authors:  Leticia Martínez-Morentin; Lidia Martínez; Sarah Piloto; Hua Yang; Eric A Schon; Rafael Garesse; Rolf Bodmer; Karen Ocorr; Margarita Cervera; Juan J Arredondo
Journal:  Hum Mol Genet       Date:  2015-03-19       Impact factor: 6.150

Review 3.  Mitochondrial cytochrome c oxidase deficiency.

Authors:  Malgorzata Rak; Paule Bénit; Dominique Chrétien; Juliette Bouchereau; Manuel Schiff; Riyad El-Khoury; Alexander Tzagoloff; Pierre Rustin
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

Review 4.  Molecular mechanisms of heart failure: insights from Drosophila.

Authors:  Shasha Zhu; Zhe Han; Yan Luo; Yulin Chen; Qun Zeng; Xiushan Wu; Wuzhou Yuan
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.